The subjects are people with normal blood pressure and people with higher blood pressure (including people with high-normal blood pressure and stage 1 hypertension). *Those who are not excluding those under 18 years old, pregnant women, and lactating women.
Conditions
Interventions
None listed
Sponsors
Oryza Oil and Fat Chemical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: P-Participant: Participant The subjects are people with normal blood pressure and people with higher blood pressure (including people with high-normal blood pressure and stage 1 hypertension). *Those who are not excluding those under 18 years old, pregnant women, and lactating women. I-intervention: Intervention (food) characteristics Continuous intake of GABA, Unlimited dosage forms, period and follow-up period. C-Comparison: Comparison Placebo (The placebo's formulation is not specified) O-Outcome: Outcome The primary outcome: systolic blood pressure and diastolic blood pressure S-Study design: Study design Randomized parallel group controlled trials, randomized crossover trials, quasi-randomized parallel group controlled trials, quasi-randomized crossover trials, non-randomized parallel group controlled trials, non-randomized crossover trials, open trials.
Exclusion criteria
Exclusion criteria: The literature which does not meet PICOS, such as conference abstracts (conference proceedings) that are not original articles will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure and diastolic blood pressure | — |
Countries
Japan
Contacts
Public ContactMarina Hirano
Oryza Oil and Fat Chemical Co., Ltd. Planning & Solution Development Department Section
Outcome results
None listed